Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tests for individual and population bioequivalence based on generalized p-values.

Richard J McNally1, Hari Iyer, Thomas Mathew

  • 1Department of Statistics, Colorado State University, Fort Collins, CO 80523, USA. mcnally@stat.colostate.edu

Statistics in Medicine
|December 18, 2002
PubMed
Summary

This study introduces a new statistical method, the generalized p-value (GPV), for assessing drug bioequivalence. The GPV method offers superior power for evaluating population bioequivalence compared to existing confidence interval approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring Moral Injury Outcome and Distress in High-Risk Populations in Germany: A Validation Study.

Assessment·2026
Same author

Research on microaggressions and their impact assesses neither microaggressions nor their impact.

Current opinion in psychology·2026
Same author

Patient profiles and disease characteristics of the IMSRN cohort: a multicentre study (2021-2025).

The Lancet regional health. Southeast Asia·2026
Same author

An unusual case of Pisa syndrome secondary to anti-IgLon 5 disease.

Clinical parkinsonism & related disorders·2026
Same author

Cytotoxic Lesions of the Corpus Callosum Patterns and Etiologies: Insights from an Indian Cohort.

Annals of Indian Academy of Neurology·2026
Same author

Unveiling Superacidity in Alcohol-BF<sub>3</sub> Complexes Using a Vibrational Probe.

The journal of physical chemistry letters·2026

Area of Science:

  • Pharmacokinetics and Biopharmaceutics
  • Statistical Methods in Drug Development
  • Regulatory Science

Background:

  • The U.S. Food and Drug Administration (FDA) is updating regulations for drug formulations, focusing on 'prescribability' and 'switchability'.
  • These regulations require assessing population and individual bioequivalence for new drug formulations.
  • Current methods rely on confidence intervals, which have limitations in assessing bioequivalence.

Purpose of the Study:

  • To propose and evaluate a novel statistical methodology for assessing population and individual bioequivalence.
  • To introduce the generalized test function (GTF) methodology and generalized p-value (GPV) for bioequivalence testing.
  • To compare the performance of the proposed GPV method against existing confidence interval methods.

Main Methods:

Related Experiment Videos

  • Application of the generalized test function (GTF) methodology by Tsui and Weerahandi.
  • Development of hypothesis tests based on generalized p-values (GPV).
  • Simulation studies to evaluate the performance and power of the GPV tests.

Main Results:

  • The proposed generalized p-value (GPV) methodology provides a robust framework for bioequivalence testing.
  • GPV tests effectively handle nuisance parameters in bioequivalence assessments.
  • Simulation results demonstrate that GPV tests perform well and offer superior power for population bioequivalence compared to confidence interval methods.

Conclusions:

  • The generalized p-value (GPV) approach is a promising alternative for regulatory bioequivalence testing.
  • This method enhances the assessment of population bioequivalence, aligning with FDA's proposed regulations.
  • The GTF methodology offers a powerful tool for statistical inference in pharmaceutical development.